Sign In
Buy QGEN
$37.56
+1.11 (+3.05%)
At Close: Jun 04, 2026
Will Qiagen (QGEN) Beat Estimates Again in Its Next Earnings Report?
01:45pm, Friday, 29'th Oct 2021
Qiagen (QGEN) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Why Qiagen (QGEN) is a Top Growth Stock for the Long-Term
11:28am, Thursday, 28'th Oct 2021
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
QIAGEN (QGEN) New Launch to Aid Global TB Elimination Targets
11:40am, Wednesday, 20'th Oct 2021
QIAGEN's (QGEN) QIAreach QuantiFERON-TB test is now accessible in high burden, low-resource regions.
3 Reasons Growth Investors Will Love Qiagen (QGEN)
03:08pm, Tuesday, 19'th Oct 2021
Qiagen (QGEN) could produce exceptional returns because of its solid growth attributes.
QIAGEN (QGEN) to Report Q3 Earnings: What's in the Cards?
04:42pm, Monday, 18'th Oct 2021
New product approvals, partnerships in the diagnostic solutions category and sustained success in other product areas are likely to have contributed to QIAGEN's (QGEN) growth.
Qiagen Secures DoD Contract To Boost Production Capacity For NeuMoDx
07:19am, Friday, 01'st Oct 2021
Qiagen NV (NYSE: QGEN) won a U.S. government contract to increase the production capacity for consumables used on its NeuMoDx 96 and 288 integrated PCR testing systems. Related Link: Qiagen's CO
QIAGEN Receives U.S. Department of Defense Contract to Further Expand Production Capacity for NeuMoDx
04:48pm, Thursday, 30'th Sep 2021
GERMANTOWN, Md. & HILDEN, Germany--(BUSINESS WIRE)---- $QGEN--QIAGEN receives U.S. Department of Defense contract to further expand production capacity for NeuMoDx.
3 Promising MedTech Stocks to Snap Up in Second-Half 2021
10:42am, Thursday, 23'rd Sep 2021
Backed by robust long-term prospects, investors can add three lucrative MedTech stocks, MMSI, ITGR and OFIX, to their watchlist.
3 Diagnostics Stocks in Focus on Biden's Delta Variant Mandate
11:27am, Tuesday, 14'th Sep 2021
Stocks like Quest Diagnostics (DGX), Quidel Corporation (QDEL) and LabCorp (LH) are the right picks now, thanks to rising COVID-19 testing demand.
QIAGEN (QGEN) to Join DAX Riding on Molecular Diagnostics Feat
10:46am, Monday, 06'th Sep 2021
QIAGEN (QGEN) is experiencing significant improvements in non-COVID areas of its molecular diagnostics portfolio.
QIAGEN to Enter the DAX – Germany's Leading Stock Market Index
04:10pm, Friday, 03'rd Sep 2021
VENLO, Netherlands & HILDEN, Germany--(BUSINESS WIRE)---- $QGEN #dax--QIAGEN to enter the DAX – Germany's leading stock market index
QIAGEN's (QGEN) Kits Hit New Milestone for Sample Preparation
12:59pm, Tuesday, 24'th Aug 2021
QIAGEN's (QGEN) consumables kits have been utilized to process more than 3 billion biological samples, emphasizing on its leading position in sample preparation.
QIAGEN Reaches Milestone With Its Kits Used to Process More Than Three Billion Biological Samples to Date
04:05pm, Monday, 23'rd Aug 2021
GERMANTOWN, Md. & HILDEN, Germany--(BUSINESS WIRE)---- $QGEN #billions--QIAGEN reaches milestone with its kits used to process more than three billion biological samples to date
QIAGEN (QGEN) Gains FDA's EUA for SARS CoV-2 Antigen Test
12:23pm, Monday, 09'th Aug 2021
QIAGEN's (QGEN) QIAreach SARS CoV-2 Antigen Test can detect SARS CoV-2 antigens in 2-15 minutes and can process an average of 30 swab samples per hour.
Qiagen's COVID-19 Antigen Test Gets FDA Emergency Use Approval
04:20pm, Friday, 06'th Aug 2021
The FDA has granted emergency use authorization (EUA) to Qiagen N.V.'s (NYSE: QGEN) QIAreach SARS CoV-2 Antigen Test.
